z-logo
open-access-imgOpen Access
In Silico Drug Repurposing of 9H-Thioxanthene Based FDA-Approved Drugs as Potent Chemotherapeutics Targeting VEGFR-2 and COX-2
Publication year - 2022
Publication title -
biointerface research in applied chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.216
H-Index - 11
ISSN - 2069-5837
DOI - 10.33263/briac134.372
Subject(s) - drug repositioning , pharmacology , drug , adme , in silico , lipinski's rule of five , repurposing , approved drug , pharmacokinetics , chemistry , medicine , biology , ecology , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here